NASDAQ:AMED • US0234361089
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AMEDISYS INC (AMED).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-04-16 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-03-04 | Stephens & Co. | Reiterate | Equal-Weight -> Equal-Weight |
| 2025-02-12 | Stephens & Co. | Reiterate | Equal-Weight -> Equal-Weight |
| 2024-07-31 | Deutsche Bank | Downgrade | Buy -> Hold |
| 2024-07-25 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2024-07-01 | William Blair | Downgrade | Outperform -> Market Perform |
| 2024-04-25 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2024-03-26 | Raymond James | Maintains | Market Perform -> Market Perform |
| 2024-03-25 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-09-14 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2023-07-31 | TD Cowen | Maintains | Market Perform -> Market Perform |
| 2023-07-27 | Credit Suisse | Reiterate | Neutral -> Neutral |
| 2023-07-06 | Jefferies | Downgrade | Buy -> Hold |
| 2023-06-28 | Benchmark | Downgrade | Buy -> Hold |
| 2023-06-27 | Benchmark | Downgrade | Buy -> Hold |
| 2023-06-27 | Truist Securities | Maintains | Hold -> Hold |
| 2023-06-07 | Truist Securities | Downgrade | Buy -> Hold |
| 2023-06-06 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2023-06-06 | Benchmark | Reiterate | Buy -> Buy |
| 2023-06-06 | Credit Suisse | Downgrade | Outperform -> Neutral |
| 2023-05-08 | TD Cowen | Maintains | Market Perform |
| 2023-05-05 | Barclays | Maintains | Equal-Weight |
| 2023-05-04 | Stephens & Co. | Reiterate | Equal-Weight |
| 2023-05-04 | Truist Securities | Maintains | Buy |
| 2023-04-21 | Cantor Fitzgerald | Initiate | Neutral |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.223B 0.41% | 2.236B 0.59% | 2.348B 5.01% | 2.496B 6.29% | 2.628B 5.29% | 2.77B 5.40% | |
| EBITDA YoY % growth | 217.7M -28.27% | 250.909M 15.25% | 270.028M 7.62% | 269.64M -0.14% | 277.84M 3.04% | 294.9M 6.14% | |
| EBIT YoY % growth | 192.8M -29.27% | 193.066M 0.14% | 209.567M 8.55% | 240.81M 14.91% | 252.2M 4.73% | 290.55M 15.21% | |
| Operating Margin | 8.67% | 8.63% | 8.92% | 9.65% | 9.60% | 10.49% | |
| EPS YoY % growth | 5.01 -15.66% | 4.29 -14.37% | 4.31 0.47% | 4.88 13.17% | 5.27 8.09% | 5.20 -1.33% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.23 23.42% | 1.17 21.66% | 1.33 6.49% | 1.55 0.34% | 1.20 -2.48% | 1.20 3.06% |
| Revenue Q2Q % growth | 632.01M 7.54% | 646.15M 8.04% | 642.52M 8.03% | 655.53M 5.41% | 652.17M 3.19% | 666.25M 3.11% |
| EBITDA Q2Q % growth | 65.981M -28.32% | 63.452M -40.49% | 71.429M -5.47% | 81.541M -21.31% | 66.539M 0.85% | 66.617M 4.99% |
| EBIT Q2Q % growth | 59.456M 26.51% | 56.855M 23.15% | 64.205M 6.78% | 74.23M 2.05% | 57.314M -3.60% | 57.248M 0.69% |
All data in USD
17 analysts have analysed AMED and the average price target is 102.87 USD. This implies a price increase of 1.87% is expected in the next year compared to the current price of 100.99.
AMEDISYS INC (AMED) will report earnings on 2025-11-04, after the market close.
The consensus EPS estimate for the next earnings of AMEDISYS INC (AMED) is 1.23 USD and the consensus revenue estimate is 632.01M USD.
The expected long term growth rate for AMEDISYS INC (AMED) is 4.95%.